Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
about
Trinucleotide repeats: a structural perspectiveA Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophyA yeast model for polyalanine-expansion aggregation and toxicityThe Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting ProteinExtraocular mitochondrial myopathies and their differential diagnoses.Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and reviewHow do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?New kid on the ID block: neural functions of the Nab2/ZC3H14 class of Cys₃His tandem zinc-finger polyadenosine RNA binding proteins.Oculopharyngeal muscular dystrophy as a rare differential diagnosis for unexplained dysphagia: a case reportPABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic CounsellingInteractions between homopolymeric amino acids (HPAAs).A nuclear ubiquitin-proteasome pathway targets the inner nuclear membrane protein Asi2 for degradation.Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions.Characterization of PABPN1 expansion mutations in a large cohort of Mexican patients with oculopharyngeal muscular dystrophy (OPMD).Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.
P2860
Q30432441-2E2FB32A-91CE-4C60-B353-B5DBAEA32AC8Q34518248-CBD430BA-4761-47C8-B76C-DADC54164BE2Q34605368-05A88E1F-0B5C-4984-BFD7-292A6E7095C8Q35041591-F45E3DE3-E36B-4274-83BC-3BAD5991A9A6Q35790486-01E86D5D-76F6-4A62-B369-D785CF959E7FQ36499611-120D8160-16E4-4DB5-A7C4-8A415D4CAA6DQ37236634-8C523CC2-74CE-46E3-BFB9-D4926B5D97E2Q38060527-0EAFFE36-DAF3-4C74-A059-1D50B923629BQ39614953-3BD78EB9-11E8-4472-9745-648452F277E1Q41823602-77EB67C1-E08B-48D9-89C4-413F38814233Q41956578-D9A8E57E-A83D-49A9-8851-2E7E427750AFQ42081147-4B8989F6-E418-46D4-8FAF-AADBD53A0F8EQ42110763-282C237C-1EEE-412B-BC04-848F68965ABFQ47351608-2E96FCCB-69B7-42D0-9C27-3FBE92B0E27FQ51259845-8F2B807E-698E-4C3C-B3A3-99ABB783F466Q51431954-BBB6AEE2-E93D-4013-9347-229B0892D204
P2860
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@ast
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@en
type
label
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@ast
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@en
prefLabel
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@ast
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@en
P356
P1476
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
@en
P2093
P304
P356
10.1159/000072861
P577
2003-01-01T00:00:00Z